Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pleural Disorders: Types and Brief Description

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.

Endocrine-related cancer·2023

Same author

Systemic Therapy for Mesothelioma: Turning the Corner.

JCO oncology practice·2021

Same author

Understanding the new therapeutic options for mesothelioma.

The Lancet. Oncology·2021

Same author

The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma.

Journal of oncology practice·2016

Same author

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2014

Same author

Current controversies in the stage-specific multidisciplinary management of pancreatic cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2014

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Update on malignant pleural mesothelioma.

Nicholas Paul Campbell¹, Hedy Lee Kindler

¹Section of Hematology-Oncology, University of Chicago Medical Center, Chicago, Illinois 60647, USA.

Seminars in Respiratory and Critical Care Medicine

|April 19, 2011

Summary

Malignant pleural mesothelioma, an aggressive cancer linked to asbestos, has varied subtypes impacting outcomes. Research is ongoing for biomarkers, surgical approaches, and novel therapies beyond standard chemotherapy.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Experiment Videos

Last Updated: Jun 2, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Area of Science:

Oncology
Environmental Medicine
Pathology

Background:

Malignant pleural mesothelioma is an aggressive cancer primarily caused by asbestos exposure.
While US incidence declines, global rates are expected to rise until asbestos use is regulated.
The disease is heterogeneous, with three subtypes significantly affecting patient prognosis.

Purpose of the Study:

To review the current understanding and management of malignant pleural mesothelioma.
To highlight key areas of ongoing research, including biomarkers, surgical techniques, and therapeutic strategies.

Main Methods:

Literature review of malignant pleural mesothelioma.
Analysis of prognostic factors, including histology and stage.
Evaluation of diagnostic biomarkers, surgical options, and chemotherapy regimens.

Main Results:

Histology is a more critical prognostic factor than stage in malignant pleural mesothelioma.
Serum mesothelin-related peptide and osteopontin show potential as biomarkers.
Pemetrexed-cisplatin chemotherapy improves survival and quality of life; optimal regimens for specific patient groups require further study.

Conclusions:

Malignant pleural mesothelioma management requires consideration of histological subtype and emerging biomarkers.
Surgical approaches and chemotherapy regimens are evolving, with novel agents under investigation.
Further research is needed to address unanswered questions regarding maintenance therapy and treatment for vulnerable patient populations.